Thioredoxin Systems AB

📍 Solna, Sweden🗓 Founded 1994👥 8 employees💰 Last funded Nov 2024
Biotechnology Research🌐 txnsystems.com
Website LinkedIn
Thioredoxin Systems AB is a biotechnology company developing a novel antibiotic regimen against pathogenic bacteria. EbsArgent is a patented combination of ebselen and silver, capable of functioning as an antiseptic, antibacterial in food production, and as a medicinal product. With its versatility and ability to act on a wide range of multi-drug resistant bacteria, it is among the most promising antibiotic regimen under development today.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
1994
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
3
Investor activity2020–2024 · investors recorded per year
2020120242
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Thioredoxin Systems AB?
Thioredoxin Systems AB has 3 investors on record on gritt.io.
When did Thioredoxin Systems AB last raise funding?
The most recent investment in Thioredoxin Systems AB recorded on gritt.io was in November 2024.
When was Thioredoxin Systems AB founded?
Thioredoxin Systems AB was founded in 1994.
What industry is Thioredoxin Systems AB in?
Thioredoxin Systems AB operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Thioredoxin Systems AB based?
Thioredoxin Systems AB is headquartered in Solna, Sweden.